Kista, Sweden

Ingmarie Höidén-Guthenberg

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ingmarie Höidén-Guthenberg: Innovator in Engineered Polypeptides

Introduction

Ingmarie Höidén-Guthenberg, a talented inventor based in Kista, Sweden, has made significant contributions to the field of biochemistry through her innovative work with engineered polypeptides. With a total of two patents to her name, her research focuses on therapeutic and diagnostic applications that can potentially transform medical practices.

Latest Patents

Höidén-Guthenberg's latest patents showcase her pioneering work in the realm of engineered polypeptides. The first patent focuses on a class of polypeptides that exhibit a binding affinity for interleukin-6 (IL-6). Specifically, it provides an IL-6 binding polypeptide with the sequence EEXXAWXEIH XLPNLXXXQXXAFIXXLXX, along with its potential use as a therapeutic, prognostic, and diagnostic agent.

The second patent relates to polypeptides that bind to carbonic anhydrase IX (CAIX). This disclosure not only details the CAIX binding polypeptide but also emphasizes its applications as a diagnostic and therapeutic agent in various medical scenarios.

Career Highlights

Ingmarie Höidén-Guthenberg is currently employed by Affibody AB, a company recognized for its cutting-edge advancements in biotechnology. Throughout her career, she has demonstrated her expertise and commitment to developing innovative solutions that address clinical challenges.

Collaborations

During her tenure at Affibody AB, Höidén-Guthenberg has collaborated with notable colleagues such as Elin Gunneriusson and Lars Abrahmsén. Their collective expertise and teamwork have contributed to the success of their projects and patents, fostering an environment of creativity and innovation.

Conclusion

Ingmarie Höidén-Guthenberg's work exemplifies the essence of innovation in the field of biotechnology. Her contributions, particularly in the realm of engineered polypeptides, hold promise for advancing therapeutic and diagnostic capabilities in medicine. As she continues to push the boundaries of scientific research, her work will undoubtedly inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…